Saved in:
| Main Authors: | , |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.17664904 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p dir="auto">Vigorous Intermittent Lifestyle Physical Activity (VILPA)—brief bouts (<1–2 minutes) of high-intensity movement performed during daily life—has emerged as a powerful predictor of cardiovascular risk reduction, particularly for middle-aged adults. Large-scale accelerometer-based evidence from the UK Biobank demonstrates that as little as 3–4 minutes/day of VILPA reduces major cardiovascular events by up to 45% in women, far outperforming equivalent durations of moderate physical activity.</p> <p dir="auto">This paper situates VILPA within the three core movement-science systems operationalized across the MMSx Authority network—the BPIT 5-Line Principle, the NEEBAL 5-Pillar Integrated Framework, and the MOVE Protocol (NCT07220200). By synthesizing UK Biobank epidemiology with authentic biomechanical observations from BPIT assessments, NEEBAL sling-integration analyses, and MOVE neuromuscular re-education data, we propose a unified mechanistic model explaining why VILPA produces exceptionally disproportionate cardiorespiratory benefits. Across BPIT and MOVE dataset observations (n = 126; age 35–62 years), VILPA-like bursts produced peak ground-reaction forces of 2.4–3.0× body weight (women 2.3–2.6×, men 2.6–3.0×) and acute arterial stiffness reductions of −0.6 to −1.2 m/s.</p> <p dir="auto">We present the first conceptual integration positioning VILPA as the lifestyle-embedded equivalent of BPIT micro-cycles, a natural expression of NEEBAL sling and fascial engagement, and a velocity-based stimulus consistent with the MOVE framework. This alignment suggests VILPA may represent an accessible, evidence-supported public-health modality that simultaneously satisfies biomechanical, neuromuscular, fascial, and cardiovascular adaptation pathways.</p>